openPR Logo
Press release

Digital Therapeutics Market reached US$ 5.7 billion in 2023 and is expected to reach US$ 27.3 billion by 2031 | Teladoc Health, 2Morrow Inc, Omada Health Inc.

01-17-2025 07:34 AM CET | Health & Medicine

Press release from: DataM Intelligence 4market Research LLP

Digital Therapeutics Market

Digital Therapeutics Market

The global digital therapeutics market reached US$ 5.7 billion in 2023 and is expected to reach US$ 27.3 billion by 2031, growing at a CAGR of 21.6% during the forecast period 2024-2031.

Digital Therapeutics Market analysis, according to DataM Intelligence, offers more than just an overview, it investigates the underlying aspects of the sector. The study provides an overview, the research explores the hidden aspects of the sector, breaking down its intricate dynamics, charting regional dominance, spotting demand patterns, and spotting prospective breakthroughs that could influence how businesses operate in the future.

Get a Free Sample PDF copy of the report - https://datamintelligence.com/download-sample/digital-therapeutics-market

The Digital Therapeutics market report majorly focuses on market trends, historical growth rates, technologies, and the changing investment structure. Additionally, the report shows the latest market insights, increasing growth opportunities, business strategies, and growth plans adopted by major players. Moreover, it contains an analysis of current market dynamics, future developments, and Porter's Five Forces Analysis.

Digital therapeutics (DTx) are evidence-based software programs that prevent, manage, or treat medical conditions. They leverage digital platforms like apps, sensors, and wearables to deliver personalized therapeutic interventions. Unlike traditional medications, DTx focuses on behavior modification and patient engagement to improve health outcomes. They are commonly used for chronic conditions like diabetes, mental health disorders, and substance abuse.

Forecast Growth Projected:

The Global Digital Therapeutics Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

List of the Key Players in the Digital Therapeutics Market:

Teladoc Health, 2Morrow Inc, Omada Health, Inc, Resmed Inc , Voluntis, Inc, Kaia Health, Biofourmis, Click Therapeutics, Inc, Welldoc's BlueStar, Lark Technologies, Inc.

Segment Covered in the Digital Therapeutics Market:

By Product Type: Software, Devices, Others.

By Application: Diabetes, Obesity, Cardiovascular Diseases (CVD), Central Nervous System (CNS) Diseases, Respiratory Diseases, Smoking Cessation, Gastrointestinal Disorders (GID), Others.

By Sales Channel: Business-to-Business (B2B) (Employer, Healthcare Providers, Payers, Pharmaceutical Companies, Others), Business-to-Consumer (B2C) (Patient, Caregiver).

Industry Development:

In August 2024, Otsuka Precision Health and Click Therapeutics introduced Rejoyn, a prescription digital therapeutic designed to treat symptoms of major depressive disorder. Cleared by the FDA in March 2024, Rejoyn is intended as an adjunct to clinician-managed outpatient care for adults aged 22 and older who are on antidepressant medication.

Get this Premium Report: https://www.datamintelligence.com/buy-now-page?report=digital-therapeutics-market

Regional Break out:

The global Digital Therapeutics Market report focuses on six major regions: North America, South America, Europe, Asia Pacific, the Middle East, and Africa.

☞ North America - US, Canada, Mexico

☞ Europe- Germany, Russia, UK, France, Italy, Rest of Europe

☞ Asia Pacific- China, India, Japan, Australia, Rest of Asia Pacific

☞ South America- Brazil, Argentina, Colombia, Rest of South America

☞ Middle East and Africa- Saudi Arabia, UAE, Oman, Bahrain, Qatar, Kuwait, Israel

Chapter Outline:

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: key insights, key emerging trends, etc.

Chapter 3: Manufacturers competitive analysis, detailed analysis of Digital Therapeutics manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 5 & 6: Revenue of Digital Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: The main points and conclusions of the report.

Speak to Our Senior Analyst and Get Customization in the report as per your requierments: https://datamintelligence.com/customize/digital-therapeutics-market

Frequently asked questions:

➠ What is the global sales value, production value, consumption value, import and export of Digital Therapeutics market?

➠ Who are the global key manufacturers of the Digital Therapeutics Industry? How is their operating situation (capacity, production, sales, price, cost, gross, and revenue)?

➠ What are the Digital Therapeutics market opportunities and threats faced by the vendors in the global Digital Therapeutics Industry?

➠ Which application/end-user or product type may seek incremental growth prospects? What is the market share of each type and application?

➠ What focused approach and constraints are holding the Digital Therapeutics market?

➠ What are the different sales, marketing, and distribution channels in the global industry?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Digital Therapeutics Market reached US$ 5.7 billion in 2023 and is expected to reach US$ 27.3 billion by 2031 | Teladoc Health, 2Morrow Inc, Omada Health Inc. here

News-ID: 3819554 • Views:

More Releases from DataM Intelligence 4market Research LLP

Europe & CIS Construction Chemicals Market Set for Robust Growth Driven by Sustainable Infrastructure and Advanced Chemical Solutions (2024-2031)
Europe & CIS Construction Chemicals Market Set for Robust Growth Driven by Susta …
The Europe and CIS Construction Chemicals Market is anticipated to grow at high CAGR during the forecast period 2024-2031 The Europe and CIS Construction Chemicals Market is driven by increasing infrastructure development, urbanization, and demand for durable and sustainable building materials. Market growth is supported by advancements in high-performance chemical solutions, rising renovation activities, and government initiatives promoting smart and green construction. ➠ Download Your Sample Report Instantly - Corporate Email ID
North America Disposable Tabletop Kitchen Products Market Expected to Grow at a CAGR of 4.7% by 2031| Key Players: Huhtamaki, Novolex, Hoffmaster, StoneStraw, Fuling Plastic
North America Disposable Tabletop Kitchen Products Market Expected to Grow at a …
The North America Disposable Tabletop Kitchen Products Market, valued at US$ 76,000 million in 2021, is projected to reach US$ 112,629.37 million by 2031, growing at a CAGR of 4.7% during the forecast period 2024-2031. The North America Disposable Tabletop Kitchen Products Market is driven by growing demand for convenient, hygienic, and sustainable dining solutions across households and foodservice sectors. Market growth is supported by the expanding quick-service restaurant industry, rising
Japan Automotive Testing, Inspection, and Certification Market to Surge from US$ 5.21 Billion in 2024 to US$ 8.65 Billion by 2032, Driven by EVs, Autonomous Vehicles, and Stringent Safety Standards
Japan Automotive Testing, Inspection, and Certification Market to Surge from US$ …
The Japan Automotive Testing, Inspection, and Certification Market was valued at US$ 5,209.00 million in 2024 and is projected to reach US$ 8,653.30 million by 2032, growing at a CAGR of 6.55% during the forecast period 2025-2032. The Japan Automotive Testing, Inspection, and Certification (TIC) Market is driven by stringent safety regulations, technological advancements in vehicles, and growing demand for quality assurance. Market growth is supported by the rise of electric
Latin America Lubricants Market to Witness Steady Growth at 3.13% CAGR Through 2030 | Key Players Include Petrobras, YPF S.A., Pemex, Texaco Lubricants, and Terpel
Latin America Lubricants Market to Witness Steady Growth at 3.13% CAGR Through 2 …
The Latin America Lubricants Market is projected to grow at a CAGR of 3.13% during the forecast period 2023-2030. The Latin America Lubricants Market is driven by rising industrialization, expanding automotive production, and increasing demand for high-performance engine oils. Market growth is supported by infrastructure development, adoption of synthetic and bio-based lubricants, and the growing focus on equipment efficiency and maintenance. ➠ Download Your Sample Report Instantly - Corporate Email ID Required

All 5 Releases


More Releases for Therapeutics

Adrenomyeloneuropathy Market: Epidemiology, Therapies, Companies, DelveInsight | …
Adrenomyeloneuropathy emerging therapies are expected to boost the Adrenomyeloneuropathy Market in the upcoming years. DelveInsight has launched a new report on "Adrenomyeloneuropathy - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Adrenomyeloneuropathy, historical and forecasted epidemiology as well as the Adrenomyeloneuropathy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Discover about the Adrenomyeloneuropathy market report @ https://www.delveinsight.com/report-store/adrenomyeloneuropathy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr Some of the
Pompe Disease Market: Epidemiology, Therapies, Companies, DelveInsight | Genzyme …
Pompe Disease emerging therapies, such as MYOZYME (alglucosidase alfa), LUMIZYME, AAV2/8-LSPhGAA, Avalglucosidase alfa, and others, are expected to boost the Pompe Disease Market in the upcoming years. DelveInsight has launched a new report on "Pompe Disease - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Pompe Disease, historical and forecasted epidemiology as well as the Pompe Disease market trends in the United States, EU5 (Germany, Spain,
Dark Genome Therapeutics Market Deep Research Report with Forecast to 2032 | myN …
The qualitative latest Research report (2025-2032) on the Dark Genome Therapeutics Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves. Request a Sample Copy: https://www.coherentmarketresearch.com/samplepages/133611 Focused on growth
Hodgkin's lymphoma Therapeutics Market Size Report 2032 | Affimed Therapeutics, …
DelveInsight's "Hodgkin's Lymphoma Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the Hodgkin's Lymphoma, historical and forecasted epidemiology as well as the Hodgkin's Lymphoma market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United kingdom and Japan. Discover Key Insights into the Hodgkin's lymphoma Market with DelveInsight's In-Depth Report @ Hodgkin's lymphoma Market Size- https://www.delveinsight.com/sample-request/hodgkins-lymphoma-hl-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr Key Takeaways from the Hodgkin's
CRISPR Therapies Pipeline 2024 | Intellia Therapeutics, CRISPR therapeutics, Rep …
DelveInsight's, "CRISPR Therapies Pipeline Insight 2024" report provides comprehensive insights about 25+ CRISPR Therapies Companies and 30+ pipeline drugs in CRISPR Therapies pipeline landscape. It covers the CRISPR Therapies pipeline drug profiles, including clinical and nonclinical stage products. It also covers the CRISPR Therapies therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive CRISPR Therapies pipeline products in this space. Key Takeaways from
Digital Therapeutics Market, Digital Therapeutics Market Size, Digital Therapeut …
The global digital therapeutics market is expected to reach US$ 8,941.1 Mn by 2025 from US$ 1,993.2 Mn in 2017. The market is estimated to grow with a CAGR of 20.8% during the forecast period from 2018 to 2025. North America is the largest geographic market and it is expected to be the largest revenue generator during the forecast period, whereas the market is expected to witness growth at a significant